AACR

The American Association for Cancer Research (AACR) Annual Meeting is one of the largest and most influential academic events in the global cancer research field, held annually in various locations across the United States. Since its inception, the AACR Annual Meeting has consistently been dedicated to promoting the integration and development of basic research, translational medicine, and clinical applications in cancer prevention, diagnosis, and treatment. Its long history and continuous innovation have made it a benchmark for global oncology research, attracting over 20,000 cancer researchers, scholars, clinicians, and industry representatives from around the world each year. The AACR Annual Meeting is not only a crucial platform for scientists, clinicians, other healthcare professionals, cancer survivors, patients, and advocates to gather, share, and discuss the latest breakthroughs, but also a core driving force against cancer progression. The conference content covers multiple dimensions, from population science and prevention, cancer biology, translational and clinical research to survivorship and advocacy, comprehensively showcasing the most cutting-edge advancements in cancer science and medicine. Past annual meetings have attracted top global cancer scientists and numerous pharmaceutical companies, such as Huason Pharmaceutical, AHR Pharmaceuticals, and Kelun Pharmaceutical, all of whom have showcased their latest research findings and innovative products. Through its broad range of topics, the AACR Annual Meeting focuses on the most cutting-edge technologies, innovative products, and research achievements in oncology, providing a vital platform for global cancer researchers to present major scientific findings and exchange the latest ideas, greatly promoting cooperation and development in global cancer research.

The American Association for Cancer Research (AACR) Annual Meeting's exhibition scope and conference topics cover all aspects of cancer research, aiming to showcase the latest advancements from basic science to clinical applications. Specific exhibits and topics include, but are not limited to: 1. <b>Cancer Biology and Pathology Research:</b> Tumorigenesis mechanisms, cell signaling pathways, genomics, proteomics, metabolomics, epigenetics, tumor microenvironment, immuno-oncology, cancer stem cell research, tumor metastasis mechanisms, drug resistance mechanisms, pathological diagnostic techniques and related equipment, etc. 2. <b>Cancer Prevention and Epidemiology:</b> Cancer risk factor research, prevention strategies, early screening technologies, biomarker discovery, population cohort studies, health education and promotion, lifestyle interventions, etc. 3. <b>Cancer Diagnosis and Imaging Technologies:</b> Molecular diagnostic technologies (e.g., liquid biopsy, gene sequencing), imaging diagnostics (e.g., MRI, CT, PET/CT, ultrasound), pathological diagnostic equipment, AI-assisted diagnostic systems, novel biomarker detection platforms, etc. 4. <b>New Advances in Cancer Treatment:</b> Precision medicine and targeted therapy, immunotherapy (e.g., CAR-T cell therapy, PD-1/PD-L1 inhibitors), cell therapy, gene therapy, radiotherapy technologies and equipment, chemotherapy drugs, endocrine therapy, Traditional Chinese Medicine anti-cancer research, combination therapy regimens, clinical trial design and progress, etc. 5. <b>Translational Medicine and Clinical Applications:</b> Translational research from laboratory to clinic, new drug development pipelines, clinical trial data, real-world evidence, personalized treatment plans, patient management and care, palliative care, etc. 6. <b>Biotechnology and R&D Services:</b> Gene editing technologies (e.g., CRISPR), high-throughput screening platforms, animal models, bioinformatics tools and software, data analysis services, preclinical research services, CRO/CDMO services, laboratory equipment and consumables, research reagents, etc. 7. <b>Big Data and Artificial Intelligence in Cancer Research:</b> Medical big data analysis, AI-assisted drug discovery, machine learning applications in diagnosis and prognosis, bioinformatics platforms, electronic health record systems, etc. 8. <b>Patient Care and Quality of Life:</b> Cancer survivor research, psychological support, rehabilitation therapy, social support, cancer awareness and education, patient rights and advocacy, etc. These exhibits and topics collectively form a comprehensive and in-depth academic exchange platform at the AACR Annual Meeting, promoting innovation and cooperation in global cancer research.

No fee information available. Please contact us for a quote.